Compare ROIV & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROIV | CAE |
|---|---|---|
| Founded | 2014 | 1947 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 10.1B |
| IPO Year | 2021 | 2002 |
| Metric | ROIV | CAE |
|---|---|---|
| Price | $28.34 | $27.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $27.56 | ★ $34.33 |
| AVG Volume (30 Days) | ★ 4.7M | 627.5K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $29,053,000.00 | N/A |
| Revenue This Year | N/A | $5.29 |
| Revenue Next Year | $385.85 | N/A |
| P/E Ratio | ★ N/A | $35.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $20.36 |
| 52 Week High | $30.33 | $34.24 |
| Indicator | ROIV | CAE |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 39.14 |
| Support Level | $26.94 | $27.53 |
| Resistance Level | N/A | $29.71 |
| Average True Range (ATR) | 1.01 | 0.84 |
| MACD | -0.26 | -0.18 |
| Stochastic Oscillator | 38.46 | 24.82 |
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.